latest news releases from the newsroom
ProtoKinetix' Synthetic Antifreeze Glycoprotein is Now Trademarked as AAGP
VANCOUVER, British Columbia, Sept. 21, 2005 (PRIMEZONE) -- After extensive testing by ProtoKinetix, Inc. (OTCBB:PKTX) on a wide range of cells and tissue, the Company has determined that their synthetic AFGP molecule is effective in increasing survival at temperatures above and below freezing. As part of ProtoKinetix' commercialization strategy, Dr. John Todd, president and CEO, announces today that this unique family of synthetic AFGP molecules will now be designated AAGP's to avoid the misconception that their effectiveness is limited to freezing temperatures. This new trademark -- AAGP(tm) -- will more accurately describe the ability of these molecules to dramatically slow the aging process (Age Arresting Glyco Protein) on blood products, organs, skin cells and cell cultures.
New Care Choices Products Put Employers, Employees in the Health Care Driver's Seat
FARMINGTON HILLS, Mich., Sept. 21, 2005 (PRIMEZONE) -- Care Choices is offering twelve new, high-deductible HMO plans that are compatible with Health Savings Accounts (HSAs). These are also referred to as Consumer-Directed Health Plans, or CDHPs. This is the second new product announcement this year from Care Choices. The health care organization introduced Care Choices PPO in August.
eTelcharge.com Provides Update on Status of Version 1.1 Alternative Online Currency
DESOTO, Texas, Sept. 21, 2005 (PRIMEZONE) -- eTelcharge.com, Inc. (the "Company") (Pink Sheets:ETLC) www.etelcharge.com, a financial diversified merchant services company, today announced that the release of Version 1.1 of its alternative online payment option has been successfully beta tested. In line with merchant requests, the Company is modifying the system to create the significant market penetration it expects when released, key in managing a burgeoning consumer market.
Law Offices Bernard M. Gross, P.C.
Law Offices Bernard M. Gross, P.C. Files Class Action Suit Against Isolagen, Inc. -- ILE
PHILADELPHIA, Sept. 21, 2005 (PRIMEZONE) -- Law Offices Bernard M. Gross, P.C. (Http://www.bernardmgross.com) announces that a class action, numbered 05cv4983, was commenced today in the United States District Court for the Eastern District of Pennsylvania, against defendants Isolagen, Inc. (AMEX:ILE) and Frank M. Delape (Chairman and interim CEO), Robert J. Bitterman (former "CEO"), Michael Macaluso (former Founder, CEO, President, and Director), Jeffrey W. Tomz (Principal Financial and Accounting Officer and Secretary), Olga Marko (Founder and former Senior Vice President and Director of Research), William K. Boss, Jr. (Founder and former Manager of International Operations and Director), and Michael Avignon (Founder and former Director) on behalf of all persons who purchased the common stock of Isolagen between March 3, 2004 and August 1, 2005, (the "Class Period"), including purchasers of Isolagen stock issued in connection with and traceable to Isolagen's offering ("June 2004 Offering") seeking remedies under the Securities Exchange Act of 1934 (the "Exchange Act"). The case is presiding before the Honorable Ronald L. Buckwalter.